A citation-based method for searching scientific literature

Meiso Hayashi, Isabelle Denjoy, Fabrice Extramiana, Alice Maltret, Nathalie Roux Buisson, Jean-Marc Lupoglazoff, Didier Klug, Miyuki Hayashi, Seiji Takatsuki, Elisabeth Villain, Joël Kamblock, Anne Messali, Pascale Guicheney, Joël Lunardi, Antoine Leenhardt. Circulation 2009
Times Cited: 292







List of co-cited articles
5684 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.
Silvia G Priori, Arthur A Wilde, Minoru Horie, Yongkeun Cho, Elijah R Behr, Charles Berul, Nico Blom, Josep Brugada, Chern-En Chiang, Heikki Huikuri,[...]. Heart Rhythm 2013
53

Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.
Thomas M Roston, Jeffrey M Vinocur, Kathleen R Maginot, Saira Mohammed, Jack C Salerno, Susan P Etheridge, Mitchell Cohen, Robert M Hamilton, Andreas Pflaumer, Ronald J Kanter,[...]. Circ Arrhythm Electrophysiol 2015
124
44

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
Silvia G Priori, Carlo Napolitano, Mirella Memmi, Barbara Colombi, Fabrizio Drago, Maurizio Gasparini, Luciano DeSimone, Fernando Coltorti, Raffaella Bloise, Roberto Keegan,[...]. Circulation 2002
729
44

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.
Christian van der Werf, Prince J Kannankeril, Frederic Sacher, Andrew D Krahn, Sami Viskin, Antoine Leenhardt, Wataru Shimizu, Naokata Sumitomo, Frank A Fish, Zahurul A Bhuiyan,[...]. J Am Coll Cardiol 2011
241
35

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
S G Priori, C Napolitano, N Tiso, M Memmi, G Vignati, R Bloise, V Sorrentino, G A Danieli. Circulation 2001
910
34

Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
A Leenhardt, V Lucet, I Denjoy, F Grau, D D Ngoc, P Coumel. Circulation 1995
603
31


Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.
Gaetano M De Ferrari, Veronica Dusi, Carla Spazzolini, J Martijn Bos, Dominic J Abrams, Charles I Berul, Lia Crotti, Andrew M Davis, Michael Eldar, Maria Kharlap,[...]. Circulation 2015
143
27

Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
Christian van der Werf, Ineke Nederend, Nynke Hofman, Nan van Geloven, Corné Ebink, Ingrid M E Frohn-Mulder, A Marco W Alings, Hans A Bosker, Frank A Bracke, Freek van den Heuvel,[...]. Circ Arrhythm Electrophysiol 2012
92
26

Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
Christina Y Miyake, Gregory Webster, Richard J Czosek, Michal J Kantoch, Anne M Dubin, Kishor Avasarala, Joseph Atallah. Circ Arrhythm Electrophysiol 2013
63
38

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.
H Lahat, E Pras, T Olender, N Avidan, E Ben-Asher, O Man, E Levy-Nissenbaum, A Khoury, A Lorber, B Goldman,[...]. Am J Hum Genet 2001
440
23

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Michael J Ackerman, Silvia G Priori, Stephan Willems, Charles Berul, Ramon Brugada, Hugh Calkins, A John Camm, Patrick T Ellinor, Michael Gollob, Robert Hamilton,[...]. Europace 2011
458
23

Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
Prince J Kannankeril, Jeremy P Moore, Marina Cerrone, Silvia G Priori, Naomi J Kertesz, Pamela S Ro, Anjan S Batra, Elizabeth S Kaufman, David L Fairbrother, Elizabeth V Saarel,[...]. JAMA Cardiol 2017
65
33

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.
Hiroshi Watanabe, Nagesh Chopra, Derek Laver, Hyun Seok Hwang, Sean S Davies, Daniel E Roach, Henry J Duff, Dan M Roden, Arthur A M Wilde, Björn C Knollmann. Nat Med 2009
372
21

Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Ferran Roses-Noguer, Julian W E Jarman, Jonathan R Clague, Jan Till. Heart Rhythm 2014
60
35

Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.
Christian van der Werf, Krystien V Lieve, J Martijn Bos, Conor M Lane, Isabelle Denjoy, Ferran Roses-Noguer, Takeshi Aiba, Yuko Wada, Jodie Ingles, Ida S Leren,[...]. Eur Heart J 2019
34
58


Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review.
Thomas M Roston, Karolina Jones, Nathaniel M Hawkins, J Martijn Bos, Peter J Schwartz, Frances Perry, Michael J Ackerman, Zachary W M Laksman, Padma Kaul, Krystien V V Lieve,[...]. Heart Rhythm 2018
35
54

Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry.
V Probst, C Veltmann, L Eckardt, P G Meregalli, F Gaita, H L Tan, D Babuty, F Sacher, C Giustetto, E Schulze-Bahr,[...]. Circulation 2010
476
18

Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.
Mette Nyegaard, Michael T Overgaard, Mads T Søndergaard, Marta Vranas, Elijah R Behr, Lasse L Hildebrandt, Jacob Lund, Paula L Hedley, A John Camm, Göran Wettrell,[...]. Am J Hum Genet 2012
219
18

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death.
N Sumitomo, K Harada, M Nagashima, T Yasuda, Y Nakamura, Y Aragaki, A Saito, K Kurosaki, K Jouo, M Koujiro,[...]. Heart 2003
238
18


Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.
Arthur A M Wilde, Zahurul A Bhuiyan, Lia Crotti, Mario Facchini, Gaetano M De Ferrari, Thomas Paul, Chiara Ferrandi, Dave R Koolbergen, Attilio Odero, Peter J Schwartz. N Engl J Med 2008
270
17

The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
Argelia Medeiros-Domingo, Zahurul A Bhuiyan, David J Tester, Nynke Hofman, Hennie Bikker, J Peter van Tintelen, Marcel M A M Mannens, Arthur A M Wilde, Michael J Ackerman. J Am Coll Cardiol 2009
198
17

Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.
Hiroshi Watanabe, Christian van der Werf, Ferran Roses-Noguer, Arnon Adler, Naokata Sumitomo, Christian Veltmann, Raphael Rosso, Zahurul A Bhuiyan, Hennie Bikker, Prince J Kannankeril,[...]. Heart Rhythm 2013
55
30


High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures".
G Michael Vincent, Peter J Schwartz, Isabelle Denjoy, Heikki Swan, Candice Bithell, Carla Spazzolini, Lia Crotti, Kirsi Piippo, Jean-Marc Lupoglazoff, Elizabeth Villain,[...]. Circulation 2009
186
17

Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.
Peter J Schwartz, Silvia G Priori, Marina Cerrone, Carla Spazzolini, Attilio Odero, Carlo Napolitano, Raffaella Bloise, Gaetano M De Ferrari, Catherine Klersy, Arthur J Moss,[...]. Circulation 2004
420
17

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
Raymond W Sy, Michael H Gollob, George J Klein, Raymond Yee, Allan C Skanes, Lorne J Gula, Peter Leong-Sit, Robert M Gow, Martin S Green, David H Birnie,[...]. Heart Rhythm 2011
115
17

Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
Silvia G Priori, Maurizio Gasparini, Carlo Napolitano, Paolo Della Bella, Andrea Ghidini Ottonelli, Biagio Sassone, Umberto Giordano, Carlo Pappone, Giosuè Mascioli, Guido Rossetti,[...]. J Am Coll Cardiol 2012
356
16

Sudden cardiac arrest associated with early repolarization.
Michel Haïssaguerre, Nicolas Derval, Frederic Sacher, Laurence Jesel, Isabel Deisenhofer, Luc de Roy, Jean-Luc Pasquié, Akihiko Nogami, Dominique Babuty, Sinikka Yli-Mayry,[...]. N Engl J Med 2008
903
16

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.
P J Laitinen, K M Brown, K Piippo, H Swan, J M Devaney, B Brahmbhatt, E A Donarum, M Marino, N Tiso, M Viitasalo,[...]. Circulation 2001
500
16

Long-term follow-up of patients with short QT syndrome.
Carla Giustetto, Rainer Schimpf, Andrea Mazzanti, Chiara Scrocco, Philippe Maury, Olli Anttonen, Vincent Probst, Jean-Jacques Blanc, Pascal Sbragia, Paola Dalmasso,[...]. J Am Coll Cardiol 2011
171
15

The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry.
Thomas M Roston, Zhiguang Yuchi, Prince J Kannankeril, Julie Hathaway, Jeffrey M Vinocur, Susan P Etheridge, James E Potts, Kathleen R Maginot, Jack C Salerno, Mitchell I Cohen,[...]. Europace 2018
38
39

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
Gust H Bardy, Kerry L Lee, Daniel B Mark, Jeanne E Poole, Douglas L Packer, Robin Boineau, Michael Domanski, Charles Troutman, Jill Anderson, George Johnson,[...]. N Engl J Med 2005
14

Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.
A J Moss, W Zareba, W J Hall, P J Schwartz, R S Crampton, J Benhorin, G M Vincent, E H Locati, S G Priori, C Napolitano,[...]. Circulation 2000
527
14

Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human.
Nathalie Roux-Buisson, Marine Cacheux, Anne Fourest-Lieuvin, Jeremy Fauconnier, Julie Brocard, Isabelle Denjoy, Philippe Durand, Pascale Guicheney, Florence Kyndt, Antoine Leenhardt,[...]. Hum Mol Genet 2012
154
14

Mapping and ablation of idiopathic ventricular fibrillation.
Michel Haïssaguerre, Morio Shoda, Pierre Jaïs, Akihiko Nogami, Dipen C Shah, Josef Kautzner, Thomas Arentz, Dietrich Kalushe, Dominique Lamaison, Mike Griffith,[...]. Circulation 2002
407
13


J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance.
Raphael Rosso, Evgeni Kogan, Bernard Belhassen, Uri Rozovski, Melvin M Scheinman, David Zeltser, Amir Halkin, Arie Steinvil, Karin Heller, Michael Glikson,[...]. J Am Coll Cardiol 2008
385
13

Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study.
Paul Khairy, Michael J Landzberg, Michael A Gatzoulis, Hugues Lucron, Jean Lambert, François Marçon, Mark E Alexander, Edward P Walsh. Circulation 2004
227
13

Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.
Jakub Sroubek, Vincent Probst, Andrea Mazzanti, Pietro Delise, Jesus Castro Hevia, Kimie Ohkubo, Alessandro Zorzi, Jean Champagne, Anna Kostopoulou, Xiaoyan Yin,[...]. Circulation 2016
125
13

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).
Constantinos O'Mahony, Fatima Jichi, Menelaos Pavlou, Lorenzo Monserrat, Aristides Anastasakis, Claudio Rapezzi, Elena Biagini, Juan Ramon Gimeno, Giuseppe Limongelli, William J McKenna,[...]. Eur Heart J 2014
498
13

Risk stratification in the long-QT syndrome.
Silvia G Priori, Peter J Schwartz, Carlo Napolitano, Raffaella Bloise, Elena Ronchetti, Massimiliano Grillo, Alessandro Vicentini, Carla Spazzolini, Janni Nastoli, Georgia Bottelli,[...]. N Engl J Med 2003
903
13

Novel insight into the natural history of short QT syndrome.
Andrea Mazzanti, Ajita Kanthan, Nicola Monteforte, Mirella Memmi, Raffaella Bloise, Valeria Novelli, Carlotta Miceli, Sean O'Rourke, Gianluca Borio, Agnieszka Zienciuk-Krajka,[...]. J Am Coll Cardiol 2014
106
13


Prevalence of the congenital long-QT syndrome.
Peter J Schwartz, Marco Stramba-Badiale, Lia Crotti, Matteo Pedrazzini, Alessandra Besana, Giuliano Bosi, Fulvio Gabbarini, Karine Goulene, Roberto Insolia, Savina Mannarino,[...]. Circulation 2009
530
13


Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes.
Silvia G Priori, Arthur A Wilde, Minoru Horie, Yongkeun Cho, Elijah R Behr, Charles Berul, Nico Blom, Josep Brugada, Chern-En Chiang, Heikki Huikuri,[...]. Europace 2013
353
12

Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.
Fernando Wangüemert, Cristina Bosch Calero, Carmelo Pérez, Oscar Campuzano, Pedro Beltran-Alvarez, Fabiana S Scornik, Anna Iglesias, Paola Berne, Catarina Allegue, Pablo M Ruiz Hernandez,[...]. Heart Rhythm 2015
26
46


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.